Selections from international journals

IF 0.2 Q4 ALLERGY
N. Heshmat
{"title":"Selections from international journals","authors":"N. Heshmat","doi":"10.21608/EJPA.2019.41540","DOIUrl":null,"url":null,"abstract":"The well-proven benefits of influenza immunization can now be made available to persons with a history of egg allergy. Individuals with diagnosed or suspected egg allergy who need an influenza vaccination should be evaluated by an allergist/immunologist for evaluation of egg allergy and for administration of the 2010-2011 trivalent influenza vaccine (TIV) if clinically indicated. Studies have suggested that influenza vaccines can be administered to patients with a history of anaphylaxis to egg without adverse effects. However, such studies are limited in number, and reactions to influenza vaccines in egg allergic persons can occur. Caution is warranted in patients with a history of anaphylaxis or where the severity of their clinical reactivity is uncertain, particularly when the ovalbumin content of the vaccine is unknown. Therefore, consultation with an allergist experienced in food allergy and anaphylaxis is strongly recommended. For the 2010-2011 influenza season, the routine practice of skin testing to the TIV is no longer recommended. Both the 2-dose (10%, 90%) and single-dose methods are appropriate for administering influenza vaccine to egg allergic individuals. Egg allergic individuals can receive TIV without prior skin testing to the vaccine, with the vaccine being administered via a 2-step graded challenge: first administer 10% of the age-appropriate dose, with a 30-minute observation after administration for symptom development. If no symptoms develop, the remaining 90% can be administered, with a 30minute observation for symptom development. The same TIV product brand should be used for booster vaccinations if possible, but it is not necessary to use the same lot. Egg allergic individuals can receive TIV without prior skin testing to the vaccine as a single, age-appropriate dose without use of graded challenge. Individuals should be observed for 30 minutes after injection for evidence of a systemic reaction. The same TIV product brand should be used for booster vaccinations, but the same lot is not necessary.","PeriodicalId":52068,"journal":{"name":"Egyptian Journal of Pediatric Allergy and Immunology","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Journal of Pediatric Allergy and Immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/EJPA.2019.41540","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

The well-proven benefits of influenza immunization can now be made available to persons with a history of egg allergy. Individuals with diagnosed or suspected egg allergy who need an influenza vaccination should be evaluated by an allergist/immunologist for evaluation of egg allergy and for administration of the 2010-2011 trivalent influenza vaccine (TIV) if clinically indicated. Studies have suggested that influenza vaccines can be administered to patients with a history of anaphylaxis to egg without adverse effects. However, such studies are limited in number, and reactions to influenza vaccines in egg allergic persons can occur. Caution is warranted in patients with a history of anaphylaxis or where the severity of their clinical reactivity is uncertain, particularly when the ovalbumin content of the vaccine is unknown. Therefore, consultation with an allergist experienced in food allergy and anaphylaxis is strongly recommended. For the 2010-2011 influenza season, the routine practice of skin testing to the TIV is no longer recommended. Both the 2-dose (10%, 90%) and single-dose methods are appropriate for administering influenza vaccine to egg allergic individuals. Egg allergic individuals can receive TIV without prior skin testing to the vaccine, with the vaccine being administered via a 2-step graded challenge: first administer 10% of the age-appropriate dose, with a 30-minute observation after administration for symptom development. If no symptoms develop, the remaining 90% can be administered, with a 30minute observation for symptom development. The same TIV product brand should be used for booster vaccinations if possible, but it is not necessary to use the same lot. Egg allergic individuals can receive TIV without prior skin testing to the vaccine as a single, age-appropriate dose without use of graded challenge. Individuals should be observed for 30 minutes after injection for evidence of a systemic reaction. The same TIV product brand should be used for booster vaccinations, but the same lot is not necessary.
国际期刊精选
有鸡蛋过敏史的人现在可以获得流感免疫接种的充分证明的好处。确诊或疑似对鸡蛋过敏的人需要接种流感疫苗,应由过敏专科医生/免疫学家评估鸡蛋过敏情况,并在临床指征时接种2010-2011年三价流感疫苗(TIV)。研究表明,流感疫苗可用于有鸡蛋过敏史的患者,而不会产生不良反应。然而,这样的研究数量有限,而且对鸡蛋过敏的人可能会对流感疫苗产生反应。有过敏史或临床反应严重程度不确定的患者应谨慎使用,特别是在疫苗卵清蛋白含量未知的情况下。因此,强烈建议咨询在食物过敏和过敏反应方面经验丰富的过敏专科医生。在2010-2011年流感季节,不再推荐对TIV进行皮肤测试的常规做法。2剂法(10%、90%)和单剂法均适用于对鸡蛋过敏者接种流感疫苗。鸡蛋过敏的个体可以在没有事先对疫苗进行皮肤试验的情况下接种TIV,疫苗通过两步分级接种:首先接种适合年龄剂量的10%,注射后30分钟观察症状发展。如果没有出现症状,则可给予剩余90%的药物,并观察30分钟以观察症状的出现。如果可能的话,应使用相同的TIV产品品牌进行加强接种,但没有必要使用相同的批次。鸡蛋过敏的个体可以在没有事先皮肤试验的情况下接种TIV疫苗,作为单一的,适合年龄的剂量,不使用分级激发。个体应在注射后观察30分钟,以确定是否有全身反应。加强疫苗接种应使用相同的TIV产品品牌,但没有必要使用相同的批号。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
33.30%
发文量
19
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信